Skip to main content
Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.260
-0.140 (-3.18%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Coya Therapeutics Revenue

In the year 2025, Coya Therapeutics had annual revenue of $7.95M with 123.57% growth. Coya Therapeutics had revenue of $3.96M in the quarter ending December 31, 2025, with 202,768.80% growth.

Revenue (ttm)
$7.95M
Revenue Growth
+123.57%
P/S Ratio
12.58
Revenue / Employee
$993,219
Employees
8
Market Cap
99.93M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20257.95M4.39M123.57%
Dec 31, 20243.55M-2.45M-40.79%
Dec 31, 20236.00M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pyxis Oncology 13.86M
NRx Pharmaceuticals 1.23M
Inovio Pharmaceuticals 65.34K
NeOnc Technologies Holdings 39.99K
Fractyl Health 3.00K
Revenue Rankings

COYA News

More News